By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014 8:26:52 AM
TxCell To Lead Positive Project To Automate First Production Step Of Ovasave®, Its Lead Personalised Cellular Immunotherapy 7/3/2014 8:47:12 AM
TxCell Participates At Two Key US Life Science Events: 2014 French Life Sciences Day, New York, US And 2014 Biotechnology Industry Organization (BIO) International Convention, San Diego, US 6/18/2014 9:03:38 AM
TxCell Granted Certificate Of GMP Compliance From ANSM For Cell Therapy Manufacturing Facility 6/12/2014 7:36:37 AM
TxCell Release: Col-Treg Granted Advanced Therapy Medicinal Product (ATMP) Classification By The European Medicines Agency 5/22/2014 10:11:51 AM
TxCell To Present An Innovative, Personalized Cell-Based Immunotherapy Approach At The 16th Biotechnology Industry Organization (BIO) CEO & Investor Conference 2014, New York, U.S.A. 2/5/2014 7:41:33 AM
TxCell To Present An Innovative, Personalized Cell-Based Immunotherapy Approach At Biotech Showcase™ 2014, San Francisco, USA 1/10/2014 3:43:07 PM
TxCell Enters Col-Treg Into Full Development For The Rare Disease Autoimmune Uveitis 1/7/2014 12:07:26 PM
TxCell Obtains Manufacturing Accreditation Status For Its French Cell Therapy Manufacturing Facility 12/3/2013 9:16:52 AM
TxCell Announces Publication of CATS1 Study Results for Antigen-Specific Treg Therapy in Crohn's Disease in Gastroenterology 10/24/2012 11:03:54 AM